KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 246 filers reported holding KARUNA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $91,309 | -95.3% | 540 | -94.0% | 0.00% | -92.9% |
Q2 2023 | $1,957,722 | +1340805.5% | 9,028 | +1021.5% | 0.01% | +1300.0% |
Q1 2023 | $146 | -6.4% | 805 | +1.3% | 0.00% | 0.0% |
Q4 2022 | $156 | -99.9% | 795 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $174,000 | +79.4% | 795 | +3.8% | 0.00% | 0.0% |
Q2 2022 | $97,000 | +11.5% | 766 | +11.7% | 0.00% | 0.0% |
Q1 2022 | $87,000 | -37.0% | 686 | -44.8% | 0.00% | 0.0% |
Q4 2021 | $138,000 | +10.4% | 1,242 | +21.2% | 0.00% | 0.0% |
Q3 2021 | $125,000 | +15.7% | 1,025 | +7.9% | 0.00% | 0.0% |
Q2 2021 | $108,000 | -5.3% | 950 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $114,000 | +17.5% | 950 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $97,000 | +94.0% | 950 | +46.2% | 0.00% | – |
Q3 2020 | $50,000 | – | 650 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |